News

AbbVie targets psychedelic-based depression drug market with $1.2 billion deal

AbbVie will buy an experimental depression drug from partner Gilgamesh Pharmaceuticals for up to $1.2 billion, the companies ...

Metformin: Science finds new benefits from an old drug

A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...
The Grand Junction Daily Sentinel12h

FDA Suspends U.S. License of Chikungunya Vaccine

The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq ...

FDA approves use of animal drugs to treat New World Screwworm

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...

US FDA approves Ionis' drug for rare genetic disorder

The U.S. Food and Drug Administration on Thursday approved Ionis Pharmaceuticals' drug to prevent instances of severe ...

FDA’s new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
STAT3d

FDA says it will publish reports of adverse events tied to drugs on daily basis

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

People’s Pharmacy: Is there a way to petition the FDA to change a drug’s classification?

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

Indole chemistry advance could accelerate drug development with precise targeting

Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core ...